<DOC>
	<DOC>NCT00606710</DOC>
	<brief_summary>The COGENT-4 Field Following Study will evaluate the clinical performance of the Boston Scientific TELIGEN 100 HE Implantable Cardioverter Defibrillator (ICD), the COGNIS 100 HE Cardiac Resynchronization Therapy ICD (CRT-D) systems and the RELIANCE 4-SITE defibrillation lead (when available). An optional sub-study will also evaluate the clinical performance of the Reverse Mode Switch (RMS) feature in the TELIGEN 100 HE DR ICD.</brief_summary>
	<brief_title>Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia, Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>ICD indication according to normal clinical practice (for those patients receiving a TELIGEN 100 HE) CRTD indication according to normal clinical practice (for those patients receiving a COGNIS 100 HE) Willing and capable of providing informed consent, undergoing a device implant, participating in all testing associated with this clinical investigation at an approved clinical investigational centre and at the intervals defined by this protocol Geographically stable patients who are available for followup at a study centre Age 18 or above, or of legal age to give informed consent specific to national law Documented life expectancy of less than six months or expected to undergo heart transplant within the next six months Patients currently requiring dialysis Women who are pregnant or plan to become pregnant. Method of assessment per physician discretion Enrolled in any concurrent study Patients implanted with the following leads which will not be abandoned: Atrial or right ventricular unipolar leads Patch defibrillation leads Noncompatible defibrillation leads (e.g. 5/6mm)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>